Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 854

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 854
---
 civil fraud or the consequences of committing a crime. The Company M&A shall provide for indemnification of the Company’ officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through willful default or their own actual fraud. The Company will enter into indemnification agreements with its directors and executive officers, agreeing to indemnify each such person and hold him harmless against expenses, judgments, fines and amounts payable under settlement agreements in connection with any threatened, pending or completed action, suit or proceeding to which he has been made a party or in which he became involved by reason of the fact that he is or was its director or officer. Except with respect to expenses to be reimbursed by it in the event that the indemnified person has been successful on the merits or otherwise in defense of the action, suit or proceeding, our obligations under the indemnification agreements are subject to certain customary restrictions and exceptions. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable. Item 21. Exhibits and Financial Statement Schedules

| Exhibit 
 Number  
 2.1#    
 3.1     |     | Description                                                                                                                                                                                                                                                                                          
 Business Combination Agreement, dated as of March 25, 2024, by and among APx Acquisition Corp. I, OmnigenicsAI Corp, Merger Sub Limited and MultiplAI Health Ltd. (included as Annex A to the proxy statement/prospectus).                                                                           
 Amended and Restated Memorandum and Articles of Association of OmnigenicsAI, dated as of March 16, 2024.                                                                                                                                                                                             |
|:--------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.2     |     | Form of Amended and Restated Memorandum and Articles of Association of OmnigenicsAI (included as Annex D to the proxy statement/prospectus).                                                                                                                                                         |
| 3.3*    |     | Amended Articles of Association of APx Acquisition Corp. I, dated February 27, 2023 of (incorporated by reference to Exhibit 3.1 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC on February 27, 2023